Market closedNon-fractional

Assertio/ASRT

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Assertio

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

Ticker

ASRT

Sector

Healthcare

Trading on

NASDAQ

Industry

Pharmaceuticals

Headquarters

Lake Forest, United States

Employees

53

Assertio Metrics

BasicAdvanced
$137M
Market cap
-
P/E ratio
-$4.06
EPS
1.00
Beta
-
Dividend rate
$137M
1
1.866
1.334
29.72
30.312
2.49%
1.35%
-172.90%
0.832
1.02
4.76
3.531
-12.40%
-330.38%
7.61%
24.19%

What the Analysts think about Assertio

Analyst Ratings

Majority rating from 2 analysts.
Buy

Assertio Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-13.88% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$32M
-1.52%
Net income
-$4.5M
-92.15%
Profit margin
-13.88%
-92.03%

Assertio Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 66.67%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.13
-$3.42
-$0.61
-$0.05
-
Expected
$0.14
$0.07
-$0.02
-$0.03
-$0.03
Surprise
-9.88%
-4,706.06%
2,950.00%
66.67%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Assertio stock?

Assertio (ASRT) has a market cap of $137M as of July 06, 2024.

What is the P/E ratio for Assertio stock?

The price to earnings (P/E) ratio for Assertio (ASRT) stock is 0 as of July 06, 2024.

Does Assertio stock pay dividends?

No, Assertio (ASRT) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next Assertio dividend payment date?

Assertio (ASRT) stock does not pay dividends to its shareholders.

What is the beta indicator for Assertio?

Assertio (ASRT) has a beta rating of 1. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell Assertio stock

Buy or sell Assertio stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing